trans-DL-1,2-Cyclopentanedicarboxylic Acid CAS 1461-97-8 Purity >97.0% Gliclazide Intermediate Factory

Name: trans-DL-1,2-Cyclopentanedicarboxylic Acid  CAS: 1461-97-8 Purity: >97.0%    Appearance: White to Off-White Crystalline Powder Intermediate of Gliclazide (CAS: 21187-98-4) High Quality, Commercial Production E-Mail: alvin@ruifuchem.com

Products Details

Chemical Properties:

Package: Bottle, Aluminium foil bag, 25kg/Cardboard Drum, or according to customer's requirement Storage Condition: Store in sealed containers at cool and dry place; Protect from light and moistureShanghai Ruifu Chemical Co., Ltd. is the leading manufacturer and supplier of trans-DL-1,2-Cyclopentanedicarboxylic Acid (CAS: 1461-97-8) with high quality, commercial production. We can provide Certificate of Analysis (COA), worldwide delivery, small and bulk quantities available, strong after-sale service. Please contact: alvin@ruifuchem.com

Item

Inspection Standard

Results

Characteristics

White to Off-White Crystalline Powder

Conforms

Loss on Drying

<0.50%

0.10%

Purity

>97.0%

97.6%

Test Standard

Enterprise Standard

Usage

Intermediate of Gliclazide (CAS: 21187-98-4)

Description:

Specifications:

Package & Storage:

Chemical Name trans-DL-1,2-Cyclopentanedicarboxylic Acid
Synonyms trans-1,2-Cyclopentanedicarboxylic Acid; trans-Cyclopentane-1,2-Dicarboxylic Acid
CAS Number 1461-97-8
CAT Number RF-PI1819
Stock Status In Stock, Production Scale Up to Tons
Molecular Formula C7H10O4
Molecular Weight 158.15
Melting Point  163.0~165.0℃ (lit.)
Density 1.396±0.06 g/cm3
Brand Ruifu Chemical

Advantages:

FAQ:

Application:

trans-DL-1,2-Cyclopentanedicarboxylic Acid (CAS: 1461-97-8) is an intermediate of Gliclazide (CAS: 21187-98-4). Gliclazide is the second generation of sulfonylurea oral hypoglycemic agents for adults with type 2 diabetes mellitus, diabetes mellitus with obesity or vascular disease. Gliclazide has the dual functions of lowering blood sugar and improving coagulation function. Gliclazide can not only improve the metabolism of diabetic patients, but also improve or delay the occurrence of diabetic vascular complications.

Contact us

Please feel free to give your inquiry in the form below We will reply you in 24 hours